Pathophysiology of Gastroesophageal Reflux Disease

2017/10/14 by Jan Tack, John E. Pandolfino · 26 citations
Medicine · #Gastroesophageal reflux and treatments #Helicobacter pylori-related gastroenterology studies #Eosinophilic Esophagitis

paper · doi:10.1053/j.gastro.2017.09.047

Citations

• The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus

Cited by

• Esophageal motility disorders after COVID-19 infection
• Complications of Antireflux Surgery. [europepmc]
• Eosinophilic esophagitis: pathophysiology and its clinical implications. [europepmc]
• Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease. [europepmc]
• Endoscopic foregut surgery and interventions: The future is now. The state-of-the-art and my personal journey. [europepmc]
• Curcumin: A Potent Protectant against Esophageal and Gastric Disorders. [europepmc]
• Prevalence and predictors of proton pump inhibitor partial response in gastroesophageal reflux disease in systemic sclerosis: a prospective study. [europepmc]
• Anti-reflux mucosal ablation (ARMA) as a new treatment for gastroesophageal reflux refractory to proton pump inhibitors: a pilot study. [europepmc]
• Gastroesophageal and gastric ultrasound in children: the state of the art. [europepmc]
• Evidence for Cytoprotective Effect of Carbon Monoxide Donor in the Development of Acute Esophagitis Leading to Acute Esophageal Epithelium Lesions. [europepmc]
• Distinct Microbiota Dysbiosis in Patients with Non-Erosive Reflux Disease and Esophageal Adenocarcinoma. [europepmc]
• Esophageal Pathophysiologic Changes and Adenocarcinoma After Bariatric Surgery: A Systematic Review and Meta-Analysis. [europepmc]
• Post-reflux swallow-induced peristaltic wave (PSPW): physiology, triggering factors and role in reflux clearance in healthy subjects. [europepmc]
• Pathophysiology and treatment options for gastroesophageal reflux disease: looking beyond acid. [europepmc]
• Prevalence and Determinants of Gastroesophageal Reflux Disease and the Risk Factors Among Adult Patients Attending Al-Iskan Primary Health Care Center in Makkah, 2020. [europepmc]
• Esophageal hypervigilance is prevalent across gastroesophageal reflux disease presentations. [europepmc]
• Gene expression profiling of inflammatory cytokines in esophageal biopsies of different phenotypes of gastroesophageal reflux disease: a cross-sectional study. [europepmc]
• 2020 Seoul Consensus on the Diagnosis and Management of Gastroesophageal Reflux Disease. [europepmc]
• Endoscopic anti-reflux therapy for gastroesophageal reflux disease. [europepmc]
• Refractory Gastroesophageal Reflux Disease: A Management Update. [europepmc]
• Effects of acids, pepsin, bile acids, and trypsin on laryngopharyngeal reflux diseases: physiopathology and therapeutic targets. [europepmc]
• GERD-related chronic cough: Possible mechanism, diagnosis and treatment. [europepmc]
• Higher Body Mass Index Is Associated With Decreased Treatment Response to Topical Steroids in Eosinophilic Esophagitis. [europepmc]
• Roles of Cytokines in Pathological and Physiological Gastroesophageal Reflux Exposure. [europepmc]
• Noninvasive electrical neuromodulation for gastrointestinal motility disorders. [europepmc]
• Neuromodulation and the Gut-Brain Axis: Therapeutic Mechanisms and Implications for Gastrointestinal and Neurological Disorders. [europepmc]